English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

China’s first TCM drug approved by the FDA for Phase III trials

Aug. 6, 2010

Tianjin-based Tasly Pharmaceutical’s Compound Danshen Dripping Pill, a China-made pill to treat cardiovascular conditions, has been tested safe and effective by the US Food and Drug Administration (FDA) and passed the US FDA's Phase II clinical trials in July.
The drug, whose domestic sales have amounted to more than one billion Yuan ($148 million) last year, is the first patented Chinese traditional medicine to enter phase III trials under the FDA.
Compound Danshen Dripping Pill is mainly used to treat angina and coronary heart diseases.